BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: MicroRNA-155 (miR-155)

January 29, 2015 8:00 AM UTC

Mouse studies suggest T cells that overexpress miR-155 could help treat cancer without requiring lymphocyte depletion and cytokine administration. In mice with subcutaneous melanoma tumors, adoptive t...